Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

OptimizeRx (OPRX) Non Operating Income (2016 - 2025)

Historic Non Operating Income for OptimizeRx (OPRX) over the last 17 years, with Q3 2025 value amounting to -$1.0 million.

  • OptimizeRx's Non Operating Income rose 2741.12% to -$1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.1 million, marking a year-over-year increase of 29.48%. This contributed to the annual value of -$5.7 million for FY2024, which is 55872.37% down from last year.
  • As of Q3 2025, OptimizeRx's Non Operating Income stood at -$1.0 million, which was up 2741.12% from -$1.5 million recorded in Q2 2025.
  • OptimizeRx's 5-year Non Operating Income high stood at $721000.0 for Q2 2023, and its period low was -$1.5 million during Q1 2024.
  • Over the past 5 years, OptimizeRx's median Non Operating Income value was $931.0 (recorded in 2021), while the average stood at -$379880.2.
  • In the last 5 years, OptimizeRx's Non Operating Income soared by 2216656666.67% in 2023 and then tumbled by 32947.37% in 2024.
  • OptimizeRx's Non Operating Income (Quarter) stood at $2382.0 in 2021, then surged by 22507.56% to $538512.0 in 2022, then tumbled by 255.24% to -$836000.0 in 2023, then crashed by 70.57% to -$1.4 million in 2024, then rose by 29.8% to -$1.0 million in 2025.
  • Its last three reported values are -$1.0 million in Q3 2025, -$1.5 million for Q2 2025, and -$1.2 million during Q1 2025.